Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
World Journal of Gastroenterology|July 9, 2008
Autoantibodies in primary sclerosing cholangitisJohannes-Roksund Hov, Kirsten-Muri Boberg, Tom-H KarlsenEbiomedicine|February 17, 2020
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directionsMarius Trøseid, Geir Øystein Andersen, Kaspar Broch, et al.Journal of Crohn'S & Colitis|December 13, 2018
Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's DiseaseAida Kapic Lunder, Linda Tøften Bakstad, Jørgen Jahnsen, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitisIna Marie Andersen, Guro Tengesdal, Benedicte Alexandra Lie, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 12, 2017
Bowel Damage in Patients With Long-term Crohn's Disease, Assessed by Magnetic Resonance Enterography and the Lémann IndexAida Kapic Lunder, Jørgen Jahnsen, Linda Tøften Bakstad, et al.Biopreservation and Biobanking|February 28, 2024
Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation KitsDarja Nikitina, Rokas Lukosevicius, Deimante Tilinde, et al.United European Gastroenterology Journal|June 8, 2017
Elevated trimethylamine-<i>N</i>-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver functionMartin Kummen, Mette Vesterhus, Marius Trøseid, et al.Gastroenterology|February 7, 2015
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing CholangitisNatalie L Berntsen, Olav Klingenberg, Brian D Juran, et al.Scandinavian Journal of Gastroenterology|January 7, 2025
Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitisGuri Fossdal, Peder Braadland, Johannes Roksund Hov, et al.JHEP Reports : Innovation in Hepatology|September 30, 2022
Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitisPeder Rustøen Braadland, Kai Markus Schneider, Annika Bergquist, et al.Pageof 4